Michael Demurjian Sells 20,000 Shares of Tyme Technologies Inc (NASDAQ:TYME) Stock

Tyme Technologies Inc (NASDAQ:TYME) major shareholder Michael Demurjian sold 20,000 shares of Tyme Technologies stock in a transaction on Monday, January 13th. The shares were sold at an average price of $1.64, for a total transaction of $32,800.00. Following the completion of the sale, the insider now owns 25,050,521 shares in the company, valued at $41,082,854.44. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Large shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Michael Demurjian also recently made the following trade(s):

  • On Monday, January 6th, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The shares were sold at an average price of $1.47, for a total transaction of $29,400.00.
  • On Monday, December 30th, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The shares were sold at an average price of $1.07, for a total transaction of $21,400.00.
  • On Monday, December 23rd, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The shares were sold at an average price of $0.97, for a total transaction of $19,400.00.
  • On Monday, December 16th, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The shares were sold at an average price of $1.05, for a total transaction of $21,000.00.
  • On Monday, December 9th, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The shares were sold at an average price of $1.08, for a total transaction of $21,600.00.
  • On Monday, December 2nd, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The shares were sold at an average price of $1.14, for a total transaction of $22,800.00.
  • On Monday, November 25th, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The shares were sold at an average price of $1.13, for a total transaction of $22,600.00.
  • On Monday, November 18th, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The shares were sold at an average price of $1.09, for a total transaction of $21,800.00.
  • On Monday, November 11th, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The stock was sold at an average price of $1.16, for a total transaction of $23,200.00.
  • On Monday, November 4th, Michael Demurjian sold 20,000 shares of Tyme Technologies stock. The stock was sold at an average price of $1.27, for a total transaction of $25,400.00.

Shares of NASDAQ:TYME opened at $1.74 on Thursday. Tyme Technologies Inc has a 52 week low of $0.92 and a 52 week high of $4.01. The stock has a market capitalization of $195.91 million, a P/E ratio of -5.44 and a beta of 0.40. The firm has a fifty day simple moving average of $1.24 and a two-hundred day simple moving average of $1.26.

Tyme Technologies (NASDAQ:TYME) last issued its quarterly earnings data on Monday, November 4th. The company reported ($0.04) EPS for the quarter, topping analysts’ consensus estimates of ($0.06) by $0.02. On average, equities research analysts forecast that Tyme Technologies Inc will post -0.21 earnings per share for the current year.

Several large investors have recently modified their holdings of the business. Squarepoint Ops LLC purchased a new position in shares of Tyme Technologies in the 3rd quarter worth $71,000. Perkins Capital Management Inc. grew its stake in shares of Tyme Technologies by 77.0% in the 3rd quarter. Perkins Capital Management Inc. now owns 142,500 shares of the company’s stock worth $170,000 after buying an additional 62,000 shares in the last quarter. Morgan Stanley grew its stake in shares of Tyme Technologies by 187.8% in the 2nd quarter. Morgan Stanley now owns 139,579 shares of the company’s stock worth $170,000 after buying an additional 91,081 shares in the last quarter. Paloma Partners Management Co purchased a new position in shares of Tyme Technologies during the 2nd quarter worth about $238,000. Finally, Bank of New York Mellon Corp boosted its stake in shares of Tyme Technologies by 5.9% during the 2nd quarter. Bank of New York Mellon Corp now owns 306,199 shares of the company’s stock worth $374,000 after purchasing an additional 17,173 shares during the period. 12.93% of the stock is owned by institutional investors and hedge funds.

A number of brokerages have commented on TYME. ValuEngine raised shares of Tyme Technologies from a “hold” rating to a “buy” rating in a research note on Wednesday, October 2nd. Zacks Investment Research cut shares of Tyme Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, January 11th.

About Tyme Technologies

Tyme Technologies, Inc, a clinical-stage biotechnology company, develops novel cancer therapeutics. It is developing SM-88, a combination therapy based on dysfunctional metyrosine derivatives in Phase II development for metastatic pancreatic cancer and biomarker-recurrent prostate cancer. The company was founded in 2011 and is headquartered in New York, New York.

Featured Article: What is a Real Estate Investment Trust (REIT)?

Insider Buying and Selling by Quarter for Tyme Technologies (NASDAQ:TYME)

Receive News & Ratings for Tyme Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tyme Technologies and related companies with MarketBeat.com's FREE daily email newsletter.